Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cipla
Colorcon
US Department of Justice
Baxter
Julphar
Novartis
Johnson and Johnson
Farmers Insurance
Accenture

Generated: October 16, 2017

DrugPatentWatch Database Preview

TRIPROLIDINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Triprolidine Hydrochloride, and when can generic versions of Triprolidine Hydrochloride launch?

Triprolidine Hydrochloride is a drug marketed by Vitarine, Pharm Assoc, Halsey, Alpharma Us Pharms, Watson Labs, Ivax Sub Teva Pharms, and Superpharm. and is included in seven NDAs.

The generic ingredient in TRIPROLIDINE HYDROCHLORIDE is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.

Summary for Tradename: TRIPROLIDINE HYDROCHLORIDE

US Patents:0
Applicants:7
NDAs:7
Bulk Api Vendors: see list37
Clinical Trials: see list2,283
Patent Applications: see list492
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRIPROLIDINE HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vitarine
TRIPROLIDINE HYDROCHLORIDE
triprolidine hydrochloride
TABLET;ORAL085610-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Superpharm
TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
pseudoephedrine hydrochloride; triprolidine hydrochloride
TABLET;ORAL088578-001Feb 21, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
TRIPROLIDINE HYDROCHLORIDE
triprolidine hydrochloride
SYRUP;ORAL085940-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Assoc
TRIPROLIDINE HYDROCHLORIDE
triprolidine hydrochloride
SYRUP;ORAL087514-001Feb 10, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Halsey
TRIPROLIDINE HYDROCHLORIDE
triprolidine hydrochloride
SYRUP;ORAL088735-001Jan 17, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
pseudoephedrine hydrochloride; triprolidine hydrochloride
TABLET;ORAL085273-001Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TRIPROLIDINE HYDROCHLORIDE
triprolidine hydrochloride
TABLET;ORAL085094-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Boehringer Ingelheim
Cerilliant
Julphar
Express Scripts
Moodys
Healthtrust
Chubb
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot